Fidelis Capital Partners, LLC Astrazeneca PLC Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 10,490 shares of AZN stock, worth $825,667. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,490
Previous 5,336
96.59%
Holding current value
$825,667
Previous $359 Million
13.9%
% of portfolio
0.05%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,269Shares Held
483MCall Options Held
5.99MPut Options Held
5.22M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.82 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.87 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.38 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.72 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.36 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $244B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...